{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:51:30Z","timestamp":1791453090752,"version":"4.3.3"},"reference-count":14,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Kyasanur Forest Disease (KFD) is a tick-borne flaviviral infection endemic to India. While neurological manifestations are recognized, new-onset refractory status epilepticus (NORSE) has not been previously reported. We describe NORSE in the setting of severe KFD-associated hyperinflammation and multiorgan dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 53-year-old previously healthy woman with virologically confirmed KFD developed generalized tonic\u2013clonic seizures that progressed to NORSE during a severe systemic illness. She had profound cytopenias, severe hepatitis, coagulopathy, myocarditis, acute kidney injury, and marked hyperferritinemia, with a peak ferritin concentration of 14,466 ng\/ml, consistent with a macrophage activation-like hyperinflammatory phenotype. Neurological evaluation demonstrated normal brain magnetic resonance imaging and non-inflammatory cerebrospinal fluid. CSF reverse-transcription polymerase chain reaction for KFD virus was negative, and no alternative evidence of central nervous system infection was identified. The patient required mechanical ventilation, multiple anti-seizure medications, continuous anesthetic therapy, ketamine, and corticosteroids for control of refractory status epilepticus. Seizure burden subsequently declined in parallel with improvement in systemic inflammation and multiorgan dysfunction. Ferritin decreased from 14,466 to 834 ng\/ml, accompanied by progressive neurological and organ recovery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NORSE may represent a rare neurological manifestation of severe KFD. In this case, the absence of demonstrable central nervous system infection, together with the temporal association between systemic hyperinflammation and seizure activity, raises the possibility that KFD-associated immune dysregulation contributed to the development of NORSE. Recognition of this potential association may be important when evaluating neurological deterioration in patients with severe KFD and hyperinflammatory multiorgan disease..<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/trstmh\/trag122","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:01:44Z","timestamp":1790164904000},"source":"Crossref","is-referenced-by-count":0,"title":["New-onset refractory status epilepticus with a hyperferritinemic hyperinflammatory phenotype in Kyasanur Forest Disease"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5926-5885","authenticated-orcid":false,"given":"Praveen Kumar","family":"Tirlangi","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education , Manipal 576104 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8022-1086","authenticated-orcid":false,"given":"Anjely","family":"Sebastian","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education , Manipal 576104 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5106-6200","authenticated-orcid":false,"given":"Muralidhar","family":"Varma","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education , Manipal 576104 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9687-2836","authenticated-orcid":false,"given":"Nitin","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Kasturba Medical College, Manipal Academy of Higher Education , Manipal 576104 ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2026100805095977100_bib1","doi-asserted-by":"publisher","first-page":"104735","DOI":"10.1016\/j.jcv.2021.104735","article-title":"Clinical and laboratory profile of patients with Kyasanur Forest Disease: a single-centre study of 192 patients from Karnataka, India","volume":"135","author":"Gupta","year":"2021","journal-title":"J Clin Virol Off Publ Pan Am Soc Clin Virol"},{"key":"2026100805095977100_bib2","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(25)00744-3","article-title":"Clinical course and neurological profile of Kyasanur Forest Disease","volume":"26","author":"Gupta","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"2026100805095977100_bib3","first-page":"597","article-title":"Difference in clinical presentation between the first and second phases of Kyasanur Forest Disease: an experience from a teaching hospital in South India","volume":"28","author":"Gupta","year":"2020","journal-title":"Infez Med"},{"key":"2026100805095977100_bib4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","article-title":"Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions","volume":"59","author":"Hirsch","year":"2018","journal-title":"Epilepsia"},{"key":"2026100805095977100_bib5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jama.2025.24175","article-title":"Precision immunotherapy to improve sepsis outcomes: the ImmunoSep randomized clinical trial","volume":"335","author":"Giamarellos-Bourboulis","year":"2026","journal-title":"JAMA"},{"key":"2026100805095977100_bib6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jns.2015.07.017","article-title":"Neurological involvement and characterization in acquired hemophagocytic lymphohistiocytosis in adulthood","volume":"357","author":"Gratton","year":"2015","journal-title":"J Neurol Sci"},{"key":"2026100805095977100_bib7","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00277-017-3035-5","article-title":"Central nervous system involvement in adults with haemophagocytic lymphohistiocytosis: a single-center study","volume":"96","author":"Cai","year":"2017","journal-title":"Ann Hematol"},{"key":"2026100805095977100_bib8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4103\/0366-6999.228234","article-title":"Central nervous system involvement in hemophagocytic lymphohistiocytosis in adults: a retrospective analysis of 96 patients in a single center","volume":"131","author":"Song","year":"2018","journal-title":"Chin Med J (Engl)"},{"key":"2026100805095977100_bib9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cytogfr.2011.01.001","article-title":"Regulation of hepatocyte fate by interferon-\u03b3","volume":"22","author":"Horras","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"2026100805095977100_bib10","doi-asserted-by":"publisher","first-page":"e70697","DOI":"10.1002\/jmv.70697","article-title":"Temporal dynamics of the immune response in severe cases of human Kyasanur Forest Disease virus (KFDV) infection","volume":"97","author":"NB","year":"2025","journal-title":"J Med Virol"},{"key":"2026100805095977100_bib11","doi-asserted-by":"publisher","first-page":"104406","DOI":"10.1016\/j.braindev.2025.104406","article-title":"Immune dysregulation in new-onset refractory status epilepticus (NORSE): current insights and therapeutic perspectives","volume":"47","author":"Hanin","year":"2025","journal-title":"Brain Dev"},{"key":"2026100805095977100_bib12","doi-asserted-by":"publisher","first-page":"1150496","DOI":"10.3389\/fneur.2023.1150496","article-title":"A practical approach to in-hospital management of new-onset refractory status epilepticus\/febrile infection related epilepsy syndrome","volume":"14","author":"Sheikh","year":"2023","journal-title":"Front Neurol"},{"key":"2026100805095977100_bib13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40263-018-0600-y","article-title":"Intravenous corticosteroids as an adjunctive treatment for refractory and super-refractory status epilepticus: an observational cohort study","volume":"33","author":"Pantazou","year":"2019","journal-title":"CNS Drugs"},{"key":"2026100805095977100_bib14","doi-asserted-by":"publisher","first-page":"108592","DOI":"10.1016\/j.clineuro.2024.108592","article-title":"Ketamine plus midazolam compared to midazolam infusion for the management of refractory status epilepticus","volume":"246","author":"Fletman","year":"2024","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article-pdf\/doi\/10.1093\/trstmh\/trag122\/71704529\/trag122.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article-pdf\/doi\/10.1093\/trstmh\/trag122\/71704529\/trag122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:10:05Z","timestamp":1791450605000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/advance-article\/doi\/10.1093\/trstmh\/trag122\/8882175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":14,"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trag122","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"article-number":"trag122"}}